"Good News", Says Adar Poonawalla After 16 European Countries Recognise Covishield

"It is indeed good news for travellers, as we see sixteen European countries recognising Covishield as an acceptable vaccine for entry," said Serum Institute of India (SII) CEO Adar Poonawalla.

Chief Executive Officer (CEO) and owner of the Serum Institute of India (SII) on Saturday said he it was good news that Covishield, the Indian version of the 16 European countries now recognised and accepted Oxford-Astrazeneca vaccine for entry of international travellers. However, he cautioned travellers to follow travel advisories that differ from country to country. "It is indeed good news for travellers, as we see sixteen European countries recognising Covishield as an acceptable vaccine for entry. However, despite being vaccinated, entry guidelines might vary from country to country, so do read up before you travel," tweeted Mr Poonawalla. The issue of the acceptance of the Covishield vaccine as proof of immunisation for travel to the EU Member States has been widely discussed recently, after several countries in the block have refused to recognise the vaccine.